echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > 【STTT】Li Lanjuan/Zheng Shusen of Zhejiang University reveals the interaction of bacteria with metabolites and genetic alterations in hepatocellular carcinoma tumors

    【STTT】Li Lanjuan/Zheng Shusen of Zhejiang University reveals the interaction of bacteria with metabolites and genetic alterations in hepatocellular carcinoma tumors

    • Last Update: 2022-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is the original of the translational medicine network, please indicate the source when reprinting

    Author: Mia

    Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, with most patients diagnosed with advanced cancer
    when treatment is largely ineffective.
    Therefore, early diagnosis is urgently needed to improve the prognosis of patients with HCC
    .

    On September 28, the team of Li Lanjuan and Zheng Shusen of Zhejiang University published a research paper entitled "Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma" online on Signal Transduction and Targeted Therapy
    。 The study revealed that the tumor microbiota is closely related
    to changes in host metabolism, epigenetics, and gene expression profile.

    background

     01 

    Although many tumors have intratumoral bacteria, the characteristics of the tumor microbiome are difficult to analyze
    due to limited detection techniques.
    Recently, Nejman et al.
    found that different tumor types have different microbiotas, and bacterial metabolism is closely related to
    clinical features.
    They identified cancer-type-specific microbial signatures
    of the microbiome from seven tumors.
    In the Cancer Genome Atlas, unique microbial reads and tags were found in tissues and blood within and between the major cancer types of 33 cancers, suggesting that the cancer microbiome may provide new information
    for cancer diagnosis.

    While better sequencing techniques have identified the intra-tumor microbiome as an important component of the tumor microenvironment, the characteristics of microbes, metabolites, and potential gene regulatory networks in HCC are unclear
    .

    Research overview

     02 

    To study the microbiome, the researchers analyzed 47 pairs of HCC tissues and normal control liver tissue
    in the First Affiliated Hospital of Zhejiang University School of Medicine.
    The researchers found that there were differences in the microbial population structure of HCC tissues at the phyla, family and genus levels, and control tissues, and that their overall microbial composition deviated significantly from normal liver tissue
    .

    The iconic microbial environment of HCC patients suggests that changes in metabolites may be influenced by the tumor microbiota
    .
    The researchers identified different metabolites using liquid chromatography-mass spectrometry (LC-MS) and found that the metabolic patterns of HCC tissue were different
    compared to normal liver tissue.

    As there is growing evidence that the microbiome influences host epigenetic regulation, the researchers analyzed the effects
    of DNA methylation on differential gene expression by measuring the transcriptome and epigenomes of five pairs of HCC tumors and normal liver tissue.
    RNA-seq showed that 737 transcripts in HCC tissue were significantly downregulated and 1004 were upregulated
    .
    Genoset enrichment analysis (GSEA) of differentially expressed genes (DEGs) showed that highly expressed genes were mainly enriched
    in cell cycles, cell cycle processes, nuclear chromosomes, protein-DNA complexes and similar pathways.

    To further understand the function of DEGs, the researchers built a protein-protein interaction network using the STRING database, identifying DNA methylation profiles
    of five pairs of HCC tissues and normal liver tissue.
    They found that the methylation patterns of these DEGs differed between HCC and normal tissues
    .
    Methylation of different regions of the genome leads to different regulatory mechanisms of
    gene expression.
    Therefore, the researchers used clustering analysis to determine the distribution of differential methylated cytosine (DMC) in the genome, analyzing
    the first 500 significantly different methylation sites.
    The analysis showed that increased DNA methylation of CpG islands within the gene promoter region inhibited transcriptional initiation, thereby silencing
    these genes.
    Conversely, decreased DNA methylation in the promoter region leads to increased
    expression of the target gene.

    Through Spearman-related analysis, the researchers found that some microorganisms, such as Halomonas, were significantly positively associated with certain metabolites and negatively correlated
    with lL-arginine, O-phosphate ethanolamine, acetaminophen, and rosmarinic acid.
    In addition, the researchers analyzed the interaction between the microbiome and the host transcriptome and found that 10 metabome-related microbial populations were closely related to 25 methylation-related
    DEGs.

    Research summary

     03 

    In summary, the microbiome, metabolome, host transcriptome, and DNA methylation of HCC tissues and paired normal tissues show several intratumoral microbial signatures
    .
    In addition, correlations between microbial species and metabolites, DNA methylation and genetic alteration, and microbial species and genetic alterations may contribute
    to a better understanding of the tumor microenvironment.
    Microbes closely related to tumorigenesis and progression may become new biomarkers in the diagnosis and prognosis
    of HCC patients.
    However, further validation of the presence of bacteria in HCC tumors and their effects on
    tumor cell phenotypes is also needed.

    Resources:

    This article is intended to introduce medical research advances and cannot be used as a reference for
    treatment options.
    For health guidance, please visit a regular hospital
    .

    Recommended Live/Events

    09/27 14:00-17:30 Shanghai

    Innovative technology to facilitate the summit forum on accurate diagnosis and treatment of tumors

    Scan the code to participate for free

    November 01-02 09:00-17:30 Chongqing

    The 1st Southwest Single Cell Omics Technology Application Forum

    Scan the code to participate for free

    November 25-27 09:00-17:30 Shanghai

    The 4th Shanghai International Cancer Congress

    Scan the code to participate

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.